Related Experiment Video
Updated: Feb 12, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
The California Multidrug-Resistant Tuberculosis Consult Service: a partnership of state and local programs
N S Shah1,2, J Westenhouse2, P Lowenthal2
1Division of Tuberculosis Elimination, National Center for HIV, Viral Hepatitis, STI and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Expert consultations for multi-drug-resistant tuberculosis (MDR-TB) increased significantly. The California MDR-TB Service achieved high treatment success rates and positive management indicators for referred patients.
Area of Science:
- Public Health
- Infectious Diseases
- Tuberculosis Research
Background:
- US CDC recommends expert consultation for multi-drug-resistant tuberculosis (MDR-TB).
- California MDR-TB Service established in 2002 for expert consultations.
- Study describes patient characteristics, treatment outcomes, and management.
Purpose of the Study:
- To analyze the characteristics of MDR-TB patients referred for consultation.
- To evaluate treatment outcomes and management indicators for MDR-TB cases receiving expert consultation.
- To assess the trend in consultation uptake over time.
Main Methods:
- Descriptive analysis of surveillance data (July 2002-December 2012).
- Assessment of clinical consultation data and WHO indicators (January 2009-December 2012).
- Inclusion of pre-extensively drug-resistant TB and extensively drug-resistant TB cases.
Main Results:
- 140 out of 339 MDR-TB patients received consultation; consultation proportion rose from 12% to 63%.
- 88% of patients completed treatment; 86% had rapid molecular drug susceptibility testing.
- 98% received at least four effective drugs; 93% achieved culture conversion within 6 months.
Conclusions:
- Consultations with the MDR-TB Service showed a temporal increase.
- High treatment success rates and positive management indicators were observed.
- Expert consultation is a valuable component in MDR-TB management.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
07:35Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
Related Concept Videos
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Preventive Healthcare Services
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Resistivity